Beatrice Yin
Inventor
Stats
- 3 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 4 US Applications Filed
- 24 Total Citation Count
- May 31, 2017 Most Recent Filing
- Jan 29, 2009 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| INSTITUTE FOR MOLECULAR BIOLOGY | 1
| 2013
|
| SLOAN-KETTERING | 1
| 2013
|
| Institute for Molecular Biology and Genetics National Academy of Science of Ukraine | 1
| 2013
|
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2
2 2 1 | 2009
2013 2015 2017 |
| INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS | 1
| 2017
|
| INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NATIONAL ACADEMY OF SCIENCE OF UKRAINE | 2
2 2 | 2009
2013 2015 |
| SLOAN-KETTERING CANCER INSTITUTE | 2
2 1 | 2013
2015 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| New York, NY, US | Jun 02, 11 - Aug 20, 19 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07K: | PEPTIDES | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 10385138 | 2019 | Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy | 0 |
| 2017/0362,336 | 2017 | Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy | 0 |
| 9701755 | 2017 | Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy | 0 |
| 2016/0009,816 | 2016 | Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy | 7 |
| 9045533 | 2015 | Membrane transporter NaPi2b (SCL34A2) epitope antibodies | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.